Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE-ICU: Inhaled Volatile Anesthetics for Sedation in COVID-19 and Hypoxic Lung Failure
NCT04415060Phase 3Active, not recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jun 2020
- Primary completion
- Mar 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of isoflurane, sevoflurane in coronavirus disease 2019 (COVID-19), hypoxic respiratory failure, sponsored by Sunnybrook Health Sciences Centre. Started Jun 2020; status: active, not recruiting.
02
Drugs
isofluranesevoflurane
03
Conditions
coronavirus disease 2019 (COVID-19)hypoxic respiratory failure
Beyond the preview
Go deeper on NCT04415060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415060.